Biomedicine & Pharmacotherapy, 2025 Optimizing mesenchymal stromal cells priming strategies for tailored effects on the secretome González-Rodríguez Y., Casado-Santos A., González-Cubero E. et al. Olink Target 48Technical StudiesTechnical EvaluationCell Culture Supernatant | | | | |
World Journal of Psychiatry, 2025 Clinical manifestations of anxiety and depression in sepsis-associated encephalopathy and multi-omics identification of cluster of differentiation 38 as an early biomarker Wu C., Zhu H., Sun Y. et al. Olink Target 96NeurologyPatient StratificationPlasma | | | | |
Nature Aging, 2025 The geroprotectors trametinib and rapamycin combine additively to extend mouse healthspan and lifespan Gkioni L., Nespital T., Baghdadi M. et al. Olink Target 96 MouseAgingPathophysiologyMouse Plasma | | | | |
Diabetology & Metabolic Syndrome, 2025 Decoding the impact of glucose-dependent insulinotropic polypeptide receptor (GIPR) agonist on cardiometabolic health: inflammatory mediators at the focus Cheng F., Niu X., Wang Y. et al. Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma | | | | |
PLOS One, 2025 Serum IL-6 and PTX3 predict severe outcome from COVID-19 in ambulatory subjects: Impact for future therapeutic decisions Poorbaugh J., Sims J., Zhang L. et al. Olink Target 96Infectious DiseasesPatient StratificationSerum | | | | |
eBioMedicine, 2025 Radiomic and proteomic signatures of body mass index on brain ageing and Alzheimer's-like patterns of brain atrophy Anagnostakis F., Kokkorakis M., Walker K. et al. Olink Explore 3072/384Metabolic DiseasesNeurologyPathophysiologyPlasma | | | | |
Diabetology & Metabolic Syndrome, 2025 Spontaneous brain activity in patients with type 2 diabetes: linking serum neuroproteins to cognitive ability Zhang Z., Wang W., Yang X. et al. Olink Target 96Metabolic DiseasesNeurologyPathophysiologyPatient StratificationSerum | | | | |
International Journal of Biological Macromolecules, 2025 Causal relationship between 91 circulating inflammatory proteins and gynecological diseases: A two-sample bidirectional Mendelian randomization study Wang J., Zhang P., Yuan J. et al. Olink Target 96OncologyGynecologyPathophysiologyPlasma | | | | |
Advanced Science, 2025 Colorectal Cancer Cells–Derived Exosomal PIK3CA Mutation DNA Promotes Tumor Metastasis by Activating Fibroblast and Affecting Tumor Metastatic Microenvironment Wang R., Li W., Lv Y. et al. Olink Target 96OncologyPathophysiologyCell Culture Supernatant | | | | |
Obesity Surgery, 2025 Changes in Inflammatory Markers Following Bariatric Surgery and the Impact of the Surgical Procedure: A 12-Month Longitudinal Study Jensen R., Thuesen A., Huang Y. et al. Olink Target 96Metabolic DiseasesPathophysiologyPlasma | | | | |
Scientific Reports, 2025 Plasma inflammation-related proteins associated with anxiety and depression disorders in IBD patients Zhou M., Zhang W., Dang Y. et al. Olink Target 96Immunological & Inflammatory DiseasesNeurologyPathophysiologyPatient StratificationPlasma | | | | |
Liver Cancer, 2025 Camrelizumab combined with Lenvatinib and RALOX-HAIC for unresectable hepatocellular carcinoma (Cal Era): a prospective, single-arm, phase II trial Zang M., Li Q., Hu X. et al. Olink Target 96OncologyImmunotherapyPatient StratificationSerum | | | | |
Nature Communications, 2025 Multi-organ metabolome biological age implicates cardiometabolic conditions and mortality risk Zalesky A., Tian Y., Ferrucci L. et al. Olink Explore 3072/384CVDAgingPathophysiologyPlasma | | | | |
Thrombosis Journal, 2025 Therapeutic targets for venous thromboemblism: proteome-wide mendelian randomization and colocalization analyses Li X., Yang C., Zhou M. et al. Olink Explore 3072/384HematologyPathophysiologyPlasma | | | | |
Infection, 2025 Antigen-specific chemokine CCL3 as a biomarker for distinguishing between recent and remote tuberculosis infection Chang C., Ma Z., Ren W. et al. Olink Target 96Infectious DiseasesPatient StratificationPlasma | | | | |
Journal of Cardiac Failure, 2025 The Association between Serially Measured Circulating Biomarker Patterns and Pulmonary Artery Pressures measured by Invasive Hemodynamic Monitoring de Jong M., Allach Y., Kamar S. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Med, 2025 Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis uncovers pathways associated with mortality Le T., van Abeelen K., Ardiansyah E. et al. Olink Target 96Infectious DiseasesPathophysiologyCSF | | | | |
Nature Communications, 2025 The health impacts and genetic architecture of food liking in cardio-metabolic diseases Jiang W., Wang H., Geng Y. et al. Olink Explore 3072/384CVDNutritional SciencePathophysiologyPlasma | | | | |
Signal Transduction and Targeted Therapy, 2025 Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study Xie M., Bao M., Dong X. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPatient StratificationPlasma | | | | |
European Neuropsychopharmacology, 2025 Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis Oliva V., Possidente C., Fanelli G. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |